John M. Coster, PhD, RPh, Director, Division of Pharmacy, Center for Medicaid and CHIP Services, U.S. Centers for Medicare and Medicaid Services (CMS), will present the sixth annual William A. Zellmer Lecture on September 15, 2015, as part of ASHP's Policy Week activities.
The location you choose for your pharmacy will greatly contribute to its success or demise.
Do DTC advertisements provide enough information about the risks and benefits of medications?
Rankings are based on the number of views and overall creativity.
Business cards continue to serve as an opportunity for human interaction in an otherwise digital world.
A target systolic blood pressure (SBP) of 120 mm Hg has outperformed the recommended 140 mm Hg target in the landmark SPRINT study.
The National Community Pharmacists Association today announced that it will collaborate with consumer-direct lab testing innovator, Ulta Lab Tests, LLC, to roll out an online community lab testing platform to participating community pharmacy members across the country.
Pharmacist management of human immunodeficiency virus (HIV) produces earlier viral suppression in treatment-naïve patients than primary care alone.
Health Mart is launching a national radio and digital advertising campaign designed to help bring more patients into Health Mart stores.
AkzoNobel has signed a multi-year agreement to purchase sustainably generated steam from Dutch energy provider Eneco.
Mylan has officially commenced its formal offer to acquire all outstanding ordinary shares of Perrigo.
All non-expired drugs produced for sterile use by Alabama-based compounder Medistat RX have been recalled due to potential contamination, the FDA is warning pharmacists.
Because I played tenor saxophone in marching band, and my wife was on the silk squad, our offspring seemed destined to participate in such a corps.
Employers with onsite pharmacies are seeing a return on investment in the form of increased medication adherence among their health plan members.
Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses how new technologies will enhance the ability of a community pharmacist to support medication adherence.
A generic equivalent to Pfizer's antifungal agent Vfend has received FDA approval.
Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses how socioeconomic factors affect adherence.
Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, talks about how he sees the role of the pharmacist changing in the next few years.
On the heels of CVS Health's 1-year anniversary of stopping tobacco sales, a viewpoint provides a detailed history of the "long, cozy" relationship between drugstore chains and tobacco companies.
Treatments skipped due to cost are at their lowest percentage since 1999.
Empathy is neither sympathy nor compassion, according to John L. Coulehan, MD, MPH, FACP, and Marian R. Block, MD, ABFP, in their book The Medical Interview.
A ticking sound coming from Auvi-Q may seem scary, but the Institute for Safe Medicine Practices (ISMP) has clarified that it's normal.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses problems associated with automation in the pharmacy dispensing process.
This weekly video program highlights the latest in pharmacy news, product news, and more.
Biogen has been named the biotechnology industry leader on the Dow Jones Sustainability World Index for the second year in a row
For the seventh consecutive year, Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry.
Congestive heart failure (CHF) patients today have similar outcomes as they did 20 years ago, regardless of advancements in care.
Pharmacy students on rotations should strive for shorter yet more frequent mid-morning breaks, as new research suggests they are the most optimal way to recharge at work.
The FDA today approved adalimumab (Humira) to treat moderate to severe hidradenitis suppurativa (HS), an inflammatory skin disease.
AkzoNobel has been ranked number one on the influential Dow Jones Sustainability Index for the fourth consecutive year.
